Works matching IS 11727047 AND DT 2022 AND VI 36 AND IP 10


Results: 7
    1
    2
    3

    Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving Natalizumab.

    Published in:
    CNS Drugs, 2022, v. 36, n. 10, p. 1121, doi. 10.1007/s40263-022-00953-x
    By:
    • Auer, Michael;
    • Bauer, Angelika;
    • Oftring, Antonia;
    • Rudzki, Dagmar;
    • Hegen, Harald;
    • Bsteh, Gabriel;
    • Di Pauli, Franziska;
    • Berek, Klaus;
    • Zinganell, Anne;
    • Berger, Thomas;
    • Reindl, Markus;
    • Deisenhammer, Florian
    Publication type:
    Article
    4
    5
    6
    7